EuroPCR 2021: Late-Breaking Science Collection
Published: 22 June 2021
-
Views:
1310
-
Likes:
7
-
Views:
1310
-
Likes:
7
-
5m 55sPart 2 | Session 1 Late Stroke after TAVI: Dr Henrik Bjursten -
8m 5s
-
10m 17sPart 2 | Session 3 The EBC Main Study: Dr David Hildick-Smith
-
7m 3sPart 2 | Session 4 2V-TAVR: Dr Uri Landes
-
4m 29sPart 2 | Session 5 The TriClip bRIGHT Study: Prof Philipp Lurz
-
4m 10sPart 2 | Session 6 The EFFECTIVENES Trial: Prof Philipp Lurz
-
4m 26s
-
7m 30sPart 2 | Session 8 TAVR for BAV Stenosis in Low Surgical Risk Patients: Dr Raj Makkar
-
9m 49sPart 2 | Session 9 2-year Results from the MAGSTEMI Trial: Dr Luis Ortega-Paz
-
3m 33sPart 2 | Session 10 Results from the Early Neo2 Registry: Dr Andreas Rück
-
8m 8sPart 2 | Session 11 Findings From the POEM Study: Dr Giulio Stefanini
-
5m 59sPart 2 | Session 12 The Portico™ NG Study: Prof Lars Søndergaard
-
6m 35sPart 2 | Session 13 Drug coated Balloons vs Drug Eluting Stents: Dr Upul Wickramarachchi
Overview
In part 1 of this video series, Prof Nicolas Van Mieghem and Dr Joost Daemen host our review series View from the Thoraxcenter. This provides a concise analysis of the highlights of EuroPCR 2021’s Late-Breaking Trials.
The Expert Interviews featured in part 2 provide a short, accessible overview of some selected trials presented at EuroPCR 2021. These videos focus on each study’s design, results and impact on future practice. Some highlights of these interviews include an overview of the Portico™ NG study from Prof Lars Søndergaard and an insightful discussion of TAVR for Bicuspid Aortic Valve Stenosis in a low-risk patient population by Dr Raj Makkar.
More from this programme
Part 1
View from the Thoraxcenter: Wrap Up
Part 2
Expert Interviews
Faculty Biographies
Nicolas M Van Mieghem
Medical Director
Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.
Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors.
His current research focuses on cerebral embolic protection during TAVI and the search for improved…
Joost Daemen
Interventional Cardiologist
Dr Joost Daemen, MD, PhD is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam.
Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.